Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Clinical trial NCT04045613 · COMPLETED

Trial details

NCT number: NCT04045613
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2019-08-02
Primary completion: 2022-10-04
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.